NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

China police probe drug-related money laundering operation after US tip

Published 06/19/2024, 07:16 AM
Updated 06/19/2024, 07:20 AM
© Reuters. FILE PHOTO: Chinese Minister of Public Security Wang Xiaohong announces the launch of the U.S.-China Counternarcotics Working Group next to U.S. Deputy Assistant to the President and Deputy Homeland Security Advisor Jen Daskal at the Diaoyutai State Guest
USD/CNY
-

By Antoni Slodkowski

BEIJING (Reuters) - Chinese police are investigating a case of illegal foreign exchange activity and money laundering after tip-offs from the United States, state media said on Wednesday, in a rare instance of collaboration on narcotics between the two superpowers.

The U.S. and China restarted talks on counter-narcotics and law enforcement cooperation at the start of the year and China's public security department lauded the case as a successful example of Sino-U.S. anti-drug cooperation.

The news appeared to corroborate information released by the U.S. Justice Department on Tuesday, alleging that Mexico's Sinaloa Cartel conspired with groups based in California and tied to Chinese underground banking to launder drug-trafficking proceeds of over $50 million.

The Justice Department said it closely coordinated with law enforcement in Mexico and China.

Chinese state media said in a brief dispatch that, following U.S. tip-offs, an investigation found that since 2017 a man surnamed Tong started a car dealership in the U.S. to sell vehicles and offer Chinese yuan and U.S. dollar exchange services for car-buying customers.

The operation later evolved into criminal activities including the illegal trading of foreign exchange, Xinhua and CCTV news outlets said, citing the public security department.

The suspect was arrested and the case is under further investigation, state media said. The superseding indictment names a man named Peiji Tong as one of the defendants.

When asked about the case at the regular news conference, China's foreign affairs ministry said, "we refer you to the competent authorities".

The United States, where fentanyl abuse has been a major cause of death, has pushed for deeper law enforcement cooperation, including on tackling illicit finance, and further controls on the chemicals that can be used to make fentanyl.

State broadcaster CCTV said China's National Health Commission has decided to include 46 substances in the "supplementary list of controlled non-pharmaceutical narcotic drugs and psychotropic drugs" from July 1.

© Reuters. FILE PHOTO: Chinese Minister of Public Security Wang Xiaohong announces the launch of the U.S.-China Counternarcotics Working Group next to U.S. Deputy Assistant to the President and Deputy Homeland Security Advisor Jen Daskal at the Diaoyutai State Guesthouse in Beijing, China, Tuesday, Jan. 30, 2024.  Ng Han Guan/Pool via REUTERS/File Photo

These developments come as Rahul Gupta, director of the White House Office of National Drug Control Policy, was expected to arrive in Beijing to meet high level Chinese officials this week.

Also on Wednesday, the National Drug Control Office released its annual drug situation report, saying that the authorities solved a total of 42,000 drug-related cases, arrested 65,000 criminal suspects and seized 25.9 tons of various drugs.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.